Christian B. Dinneen-Long
General Counsel at GLYCOMIMETICS, INC.
Profile
Christian B.
Dinneen-Long is currently serving as the Secretary, Vice President & Corporate Counsel at GlycoMimetics, Inc. Prior to this, he held positions as the Assistant General Counsel at Guilford Pharmaceuticals, Inc., the Associate General Counsel at Emergent BioSolutions, Inc., and the Senior Counsel at Medimmune, Inc. Mr. Dinneen-Long completed his undergraduate degree at the University of Wisconsin and his graduate degree at Chicago-Kent College of Law.
Christian B. Dinneen-Long active positions
| Companies | Position | Start |
|---|---|---|
| GLYCOMIMETICS, INC. | General Counsel | 28/04/2019 |
Former positions of Christian B. Dinneen-Long
| Companies | Position | End |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | General Counsel | - |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | General Counsel | - |
| Medimmune, Inc. | General Counsel | - |
Training of Christian B. Dinneen-Long
| Chicago-Kent College of Law | Graduate Degree |
| University of Wisconsin | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GLYCOMIMETICS, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Medimmune, Inc. | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
- Stock Market
- Insiders
- Christian B. Dinneen-Long
